Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_12000 details
Primary information
SALIDSAL_12000
Biomarker nameVascular endothelial growth factor
Biomarker TypeDiagnostic
Sampling MethodUnstimulated whole saliva and serum samples was collected from 78 individuals, including 40 periodontitis patients (20 smokers and 20 nonsmokers) and 38 periodontally healthy controls (20 smokers and 18 nonsmokers).
Collection MethodAt least 3 ml of saliva was collected, and the samples were stored directly at -80 degreeC prior to analyses.
Analysis MethodLuminex Assay
Collection SiteSaliva
Disease CategoryDental Disorder
Disease/ConditionPeriodontitis
Disease SubtypeNA
Fold Change/ ConcentrationNA
Up/DownregulatedNA
ExosomalNA
OrganismHomo sapiens
PMID32643086
Year of Publication2020
Biomarker IDQ9UNS8
Biomarker CategoryProtein
SequenceMNFLLSWVHWSLALLLYLHHAK
Title of studySalivary and serum markers of angiogenesis in periodontitis in relation to smoking
Abstract of studyOBJECTIVE: Angiogenesis is essential in maintenance of periodontal homeostasis, and it is regulated by growth factors and cytokines, including basic fibroblast growth factor (b-FGF), endoglin, platelet and endothelial cell adhesion molecule (PECAM-1), vascular endothelial growth factor (VEGF), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1). In this study, the salivary and serum concentrations of these angiogenesis-related proteins in relation to smoking and periodontitis were examined.MATERIAL AND METHODS: Full-mouth periodontal status together with unstimulated whole saliva and serum samples was collected from 78 individuals, including 40 periodontitis patients (20 smokers and 20 nonsmokers) and 38 periodontally healthy controls (20 smokers and 18 nonsmokers). The Luminex®-xMAP™ technique was used for protein analyses.RESULTS: Concentrations of all tested proteins in saliva as well as VEGF in serum were significantly higher in periodontitis patients than in healthy controls. In smokers, serum concentrations of endoglin (p = 0.017) and sICAM-1 (p = 0.001) were elevated in comparison to nonsmokers. After adjusting for smoking and gender, periodontitis associated significantly with salivary concentrations of b-FGF, PECAM-1, VEGF, sICAM-1, and sVCAM-1 (p < 0.01).CONCLUSION: Taken together, salivary concentrations of b-FGF, PECAM-1, and VEGF associate with periodontitis. The suppressive effect of smoking on salivary marker levels is limited to periodontitis patients only.CLINICAL RELEVANCE: Smoking-related suppression of salivary marker levels is observed only in periodontitis patients.